AlfreyAC, MishellJM, BurksJ, Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Int Organs1972; 18: 257–61.
BakirAA, HryhorczukDO, BermanE, DuneaG.Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. Trans Am Soc Artif Intern Organs1986; 32: 171–6.
12.
MahurkarSD, MeyersL, CohenJ, KamathVK, DuneaG.Electroenecephalographic and radionuclide studies in dialysis dementia. Kidney Int1978; 13: 306–15.
13.
Noriega-SanchezA, Martinez-MoldonadoM, HaiffeRM. Clinical and electroenecephalographic changes in progressive uremic encephalopathy. Neurology1978; 28: 667–9.
14.
ClarksonEM, HinsonLWV, BaileyRR, The effect of aluminum hydroxide on calcium, phosphorus, and aluminum balances, the serum parathyroid concentration and the aluminum content of bone in patients with chronic renal failure. Clin Sci1972; 43: 519–31.
15.
KaehneyWD, HeggAP, AlfreyAC. Gastrointestinal absorption of aluminum from aluminum-containing antacids. New Eng J Med1977; 296: 1389–90.
16.
MasselotJP, AdhemarJP, JandonMC, KleinknechtD, GalliA.Reversible dialysis encephalopathy: role for aluminum-containing gels. Lancet1978; 2: 1386–7.
17.
NathanE, PedersenSE. Dialysis encephalopathy in a non-dialyzed uremic boy treated with aluminum hydroxide orally. Acta Paediat Scand1980; 69: 793–6.
18.
SedmanAB, MillerNL, WaradyBA, LumGM, AlfreyAC. Aluminum loading in children with chronic renal failure. Kidney Int1984; 26: 201–4.
19.
BakirAA, HryhorczukDO, HesslSM, BermanE, SpenglerR, DuneaG.Hyperaluminemia and fatal encephalopathy in azotemic patients taking aluminum hydroxide: the influence of age and citrate intake (Abstract). 10th Internat Congr Nephrol1987; 3.
20.
BakirAA, HryhorczukDO, AhmedS, Hyperaluminemia in renal failure: the influence of age and citrate intake. Clin Nephrol1989; 31: 40–4.
21.
SlaninaP, FalkenbornY, FrechW, CedergrenA.Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Fed Chem Toxic1984; 22: 391–7.
22.
SlaninaP, FrechW, BernhardsonA, CedergrenA, PattersonP.Influence of dietary factors on aluminium absorption and retention in the brain and bone of rats. Acta Pharmacol Toxicol1985; 56: 331–6.
23.
PattnaikR, PaniS.Studies on the citrate complex of aluminum (III). J Indian Chem Soc1961; 38: 379–84.
24.
TrappGA. Interactions of aluminum with cofactors, enzymes, and other proteins. Kidney Int1986; 29 (Suppl 18): 12–6.
25.
KingS, SavoryJ, WillsM.Aluminum distribution in serum following hemodialysis. Annals Clin Lab1982; 12: 143–9.
26.
ThomasW, MeyerJ.Aluminum-induced osteomalacia: an explanation. Am J Nephrol1984; 4: 201–3.
27.
SalninaP, FreehW, EkstromL, LoofL, SlorachS, CedergrenA.Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem1986; 32: 539–41.
MischelMG, SaluskyIB, GoodmanWG, CoburnJW. Calcium citrate markedly augments aluminum absorption in man (Abstract). Kidney Int1989; 35: 399.
30.
FomentDH, MolitorisBA, AlfreyAC. Mechanism of enhanced gastrointestinal absorption of aluminum by citrate (Abstract). Am Soc Nephrol1988, 250.
31.
McDermottJ, SmithA, IqbalK, WisneiwskiH.Aluminium and Alzheimer's disease. Lancet1977; 2: 710–1.
32.
Crapper McLachlanDR. Aluminum and Alzheimer's disease. Neurobiol of Aging1986; 7: 525–32.
33.
SherrardDJ, WalkerJV, BoykinJL. Precipitating of dialysis dementia by deferroximine treatment of aluminum-related bone disease. Am J Kidney Dis1988; 12: 126–30.
34.
AndressDL, KoppJB, MaloneyNA, CoburnJW, SherrardDJ. Early deposition of aluminum in bone in diabetic patients on hemodialysis. New Eng J Med1987;316: 292–6.
35.
CoburnJW, RobertsonJA, NorrisKC, SaluskyIB, GoodmanWG. Effect of ranitidine on aluminum absorption in man (Abstract). Am Soc Nephrol1988, 250.
36.
FournierA, MoriniereP, SebertJL, Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia and hyperparathyroidism in uremia. Kidney Int1986; 29 (Suppl 18): 114–9.
